Antihypertensive Medications and the Risk of Incident Type 2 Diabetes
Response to Gosmanov et al.
- Eric N. Taylor, MD, MSC1 and
- Gary C. Curhan, MD, SCD12
- 1Channing Laboratory and Renal Division, Brigham and Women’s Hospital, Boston, Massachusetts
- 2Departments of Nutrition and Epidemiology, Harvard School of Public Health, Boston, Massachusetts
- Address correspondence to Eric N. Taylor, MD, MSc, Channing Laboratory, Third Floor, Brigham and Women’s Hospital, 181 Longwood Ave., Boston, MA 02115. E-mail: entaylor{at}partners.org
We thank Gosmanov et al. (1) for their comments. As stated in our article (2) and the accompanying editorial (3), data on the specific use of ACE inhibitors were obtained only in the Nurses’ Health Study (NHS) I and data …
